TrialMedicine2020

Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.